Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM:PBLA) through any online brokerage.
There are no as such competitors for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. has a consensus price target of $25.00.
The stock price for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM: PBLA) is $0.0111 last updated September 24, 2026 at 10:31 AM EDT.
There are no upcoming dividends for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.